The US Food and Drug Administration (FDA) has approved treprostinil inhalation powder (YUTREPIA), a prostacyclin analog ...

The FDA also approved treprostinil (Yutrepia) inhalation powder for patients with pulmonary arterial hypertension and ...

Keros Therapeutics Inc (NASDAQ:KROS) released topline data from the TROPOS Phase 2 trial of cibotercept (KER-012) in ...

Researchers used PET/MRI to detect otherwise invisible inflammation. Less clear is how this might influence patient care.

Discover 8 key causes of bloody cough from infections to lung conditions. Learn when coughing blood needs medical attention ...

Detailed price information for Keros Therapeutics Inc (KROS-Q) from The Globe and Mail including charting and trades.

Prevent non-communicable diseases by reducing salt intake, a cost-effective way to improve public health globally.

Being exposed to lingering fine particulate matter (PM2.5) from wildfire smoke can have health effects up to three months ...

Poster Presentation: Pharmacokinetics (PK), Pharmacodynamics (PD), and Safety of the Novel Oral Fetal Hemoglobin (HBF) Inducer Pociredir in Healthy Adults in a Phase 1 study (PF1170 - Friday, June 13) ...

Learn 12 critical neurological warning signs that demand emergency care. Recognize dangerous combinations of dizziness, ...

In a significant step towards advancing specialized cardiopulmonary care, Kauvery Hospital, Vadapalani, inaugurated its ...

Microplastics in drinking water present serious health risks, with their pervasive presence raising concerns about human exposure and environmental impact.